Ajani JA - Search Results

1

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: ajani ja. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

2

Phase II trial of fazarabine in advanced colorectal carcinoma.

Hubbard KP, Daugherty K, Ajani JA, Pazdur R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: ajani ja. Invest New Drugs. 1992 Apr;10(1):39-42. doi: 10.1007/BF01275479. Invest New Drugs. 1992. PMID: 1376722 Clinical Trial.

3

Phase II study of didemnin B in advanced colorectal cancer.

Jones DV Jr, Ajani JA, Blackburn R, Daugherty K, Levin B, Patt YZ, Abbruzzese JL. Jones DV Jr, et al. Among authors: ajani ja. Invest New Drugs. 1992 Aug;10(3):211-3. doi: 10.1007/BF00877248. Invest New Drugs. 1992. PMID: 1428730 Clinical Trial.

4

Evaluation of oral etoposide in patients with metastatic gastric carcinoma: a preliminary report.

Ajani JA, Dumas P. Ajani JA, et al. Semin Oncol. 1992 Dec;19(6 Suppl 14):45-7. Semin Oncol. 1992. PMID: 1488653 Clinical Trial.

5

Metastatic glucagonoma: clinical response to a combination of 5-fluorouracil and alpha-interferon.

Jones DV Jr, Samaan NA, Sellin RV, Ajani JA. Jones DV Jr, et al. Among authors: ajani ja. Am J Med. 1992 Sep;93(3):348-9. doi: 10.1016/0002-9343(92)90246-8. Am J Med. 1992. PMID: 1524091 No abstract available.

6

Prolonged chemotherapy for localised squamous carcinoma of the oesophagus.

Ajani JA, Ryan B, Rich TA, McMurtrey M, Roth JA, DeCaro L, Levin B, Mountain C. Ajani JA, et al. Eur J Cancer. 1992;28A(4-5):880-4. doi: 10.1016/0959-8049(92)90140-w. Eur J Cancer. 1992. PMID: 1524915

7

A phase II trial of 5-fluorouracil and recombinant alpha-2a-interferon in previously untreated metastatic gastric carcinoma.

Pazdur R, Ajani JA, Winn R, Bearden J, Belt RJ, Pilat S, Hallinan R, Levin B. Pazdur R, et al. Among authors: ajani ja. Cancer. 1992 Feb 15;69(4):878-82. doi: 10.1002/1097-0142(19920215)69:4<878::aid-cncr2820690407>3.0.co;2-0. Cancer. 1992. PMID: 1735078 Clinical Trial.

8

Phase II study of intravenous 6-thioguanine in patients with advanced gastric carcinoma.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Wiseman C, Lenado-Lee MA, Patt YZ, Krakoff IH. Ajani JA, et al. Invest New Drugs. 1991 Aug;9(3):257-9. doi: 10.1007/BF00176979. Invest New Drugs. 1991. PMID: 1783525 Clinical Trial.

9

Phase II study of amonafide in advanced pancreatic adenocarcinoma.

Linke K, Pazdur R, Abbruzzese JL, Ajani JA, Winn R, Bradof JE, Daugherty K, Levin B. Linke K, et al. Among authors: ajani ja. Invest New Drugs. 1991 Nov;9(4):353-6. doi: 10.1007/BF00183580. Invest New Drugs. 1991. PMID: 1804812 Clinical Trial.

10

Phase II study of intravenous 6-thioguanine in patients with advanced carcinoma of the pancreas.

Ajani JA, Pazdur R, Winn RJ, Abbruzzese JL, Levin B, Belt R, Young J, Patt YZ, Krakoff IH. Ajani JA, et al. Invest New Drugs. 1991 Nov;9(4):369-71. doi: 10.1007/BF00183584. Invest New Drugs. 1991. PMID: 1804816 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters